Articles Referencing AMGN

Sanofi/REGN Commence Enrollment - Analyst Blog

5/15/2013, 5:28 pm from Zacks.com in Investing, Business, Stocks

Sanofi ( SNY ) and partner Regeneron Pharmaceuticals, Inc. ( REGN ) recently announced that they started enrolling patients for two phase III trials (SARIL-RA COMPARE and SARIL-RA... Read >>

Amgen to Set Up JV in China - Analyst Blog

5/14/2013, 5:05 pm from Zacks.com in Investing, Business, Stocks

Amgen ( AMGN ) recently announced its intention to set up a joint venture (JV) in China with Zhejiang Beta Pharma Co., Ltd.  The JV will focus on the commercialization of Amgen's... Read >>

Stock Market News for May 14, 2013 - Market News

5/14/2013, 10:36 am from Zacks.com in Investing, US Markets

Major indices finished mixed following better-than-expected retail sales data and discouraging economic reports from China. Investors are also concerned that, in light of encouraging... Read >>

Stock Market News for May 13, 2013 - Market News

5/13/2013, 10:18 am from Zacks.com in Investing, US Markets

Benchmarks finished in the green riding on positive investor sentiment. A few better-than-expected corporate results added to the prevailing optimism. Meanwhile, the Federal Reserve... Read >>

Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013

5/13/2013, 7:39 am from NASDAQ.com News in News Headlines, Stocks

Amgen Inc. ( AMGN ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on June 07, 2013. Shareholders who purchased AMGN stock... Read >>

Q1 Revenue In-Line. Amgen Deal Is Encouraging - Analyst Blog

5/10/2013, 9:24 am from Zacks.com in Investing, Business, Stocks

By Brian Marckx, CFA Q1 2013 RESULTS: Revenue In-Line, EPS Miss on Higher SG&A.  Amgen Deal is Encouraging… Transgenomic (OTC: TBIO ) reported financial results for Q1... Read >>

S&P Highlights Biotech ETFs

5/10/2013, 7:39 am from Benzinga in Investing, ETFs, Investing Ideas

Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple... Read >>

Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy

5/9/2013, 12:55 pm from David Moenning in Investing, Investing Ideas, Stocks, US Markets

  SoTM Bull's Eye Report - Today's Most Compelling Buy Thursday, May 9, 2013 At StateoftheMarkets.com , we strive to "own the best and ignore the... Read >>

X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 14

5/7/2013, 9:07 am from Minyanville in Investing, Stocks

Many stocks will reach their ex-dividend date next Tuesday, which is significant for investors as the seller of the stock on that date, not the buyer, receives the most recent dividend. A... Read >>

Techne Corporation (TECH) Ex-Dividend Date Scheduled for May 08, 2013

5/7/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks

Techne Corporation ( TECH ) will begin trading ex-dividend on May 08, 2013. A cash dividend payment of $0.3 per share is scheduled to be paid on May 24, 2013. Shareholders who purchased TECH... Read >>

Top Fund Buys Focus On Defensive Stocks, Housing

5/2/2013, 5:45 pm from Investor's Business Daily in Investing, Mutual Funds

April notched another month of gains for the stock market. That's four straight months so far this year. But this market rally is getting long in the tooth and top fund managers have been... Read >>

Earnings Beat at Hospira - Analyst Blog

5/1/2013, 1:10 pm from Zacks.com in Investing, Business, Earnings, Stocks

Hospira Inc. 's ( HSP ) first quarter 2013 adjusted earnings of 52 cents per share beat the Zacks Consensus Estimate of 44 cents. Higher-than-expected revenues led to the earnings beat.... Read >>

Is the Biotech Sector Still a Market Leader? - Real Time Insight

4/25/2013, 11:18 am from Zacks.com in Investing, Stocks

The biotechnology sector has been a strong performer for much of 2013. The space has seen huge gains over and above that of the broad market, with biotech benchmarks outpacing the S&P... Read >>

Stocks Market News for April 25, 2013 - Market News

4/25/2013, 10:13 am from Zacks.com in Investing, US Markets

A sharp fall in durable orders coupled with disappointing data from Procter & Gamble and AT&T dragged the Dow Jones into negative territory on Wednesday. But the S&P... Read >>

Stock Upgrades: Yesterday's Mutiny Provides Bounty for P&G Shareholders

4/25/2013, 9:20 am from Minyanville in Investing, Stocks

A day after effortlessly shrugging off the Syrian Electronic Army , the Dow (^DJI) decided to have a Road to Damascus conversion. Turnaround Tuesday arrived 24 hours late, with blue chips... Read >>